New Mayo Clinic CTSA director (principal investigator) named
The Mayo Clinic Center for Translational Sciences Activities (CTSA) is pleased to announce Sundeep Khosla, M.D., as the new director of the CTSA and principal investigator of the National Institutes of Health (NIH) CTSA grant effective June 1, 2013.
Dr. Khosla served as the CTSA co-principal investigator and director for Research Resources since 2011. Prior to 2011, he served as the CTSA associate director for Research Resources.
Dr. Khosla has extensive research experience in translational research as well as national and institutional administrative experience. He holds a significant Mayo Clinic leadership role as an associate dean for research and is on the Mayo Clinic Research Committee.
Dr. Khosla is a professor of medicine and physiology in the College of Medicine, Mayo Clinic. He is the principal investigator on a program project grant, "Physiology of Bone Metabolism in an Aging Population," and the principal investigator on an R01, "Epidemiology of Age-Related Bone Loss and Fractures."
As CTSA director, Dr. Khosla is responsible for the strategic and operational management of the CTSA. He is the lead interface for all CTSA-related activities between Mayo Clinic and the NIH. He also manages and coordinates the relationship between the CTSA, Mayo Clinic research governance and the Mayo Clinic Board of Governors. He leads Mayo's adoption and implementation of CTSA consortium-wide practices and policies.
The Mayo Clinic CTSA thanks Robert A. Rizza, M.D., for his role as the CTSA director and principal investigator. Dr. Rizza served as the principal investigator since the CTSA's inception in 2006.